War is pushing us to a drug resistance tipping point. In his latest piece for @financialtimes.com, GARDP’s Manica Balasegaram highlights how the failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere. Read more 👇 www.ft.com/content/978b...

📢 10 days left to submit abstracts for #ACC2026! Researchers and professionals at the forefront of #AMR will present their work at our virtual open access conference on 4-5 February 2026. Submit your abstract by 1700 GMT on 14 November 2025 via our online submission form. 🔗https://bit.ly/4hHLJVb

We’re excited to share that 1,052 people joined our latest #REVIVE webinar — our biggest yet!🎉 Since 2018, these webinars have brought together researchers and innovators to strengthen antimicrobial R&D. Missed it? Watch our AI-focused session here 👇 🔗 bit.ly/48ZxRDo

Our DER team has been out at key scientific forums this year, presenting work in early antibiotic discovery. Take a look at their posters👇

🌍 The ComBac-Africa website is now live! GARDP is proud to be a partner in this consortium of 12 institutions across 7 countries working to tackle multidrug-resistant Gram-negative bacteria through diagnostics, antimicrobial stewardship and a One Health approach. 🔗 www.combac-africa.org

⏰ Don’t miss your chance to present at #ACC2026! Submit your oral or poster abstract by 14 Nov 2025 (17:00 GMT). Make sure to follow the submission guidelines carefully. Submit now 🔗 acc-conference.com#posters

🔴 Live TODAY! Join our #REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions) on how AI can help detect and predict antimicrobial resistance. 🗓️17:00–18:30 CET 👉 Join here: go.bsky.app/redirect?u=h... #AMR #Antibiotics #AI #REVIVE

📢 Last chance to register! How can #AI help detect and predict antimicrobial resistance? Join our REVIVE webinar with Adrian Egli (University of Zürich) & Javier Fernández Domínguez (Pragmatech AI Solutions). 🗓️ 28 Oct 2025 | 17:00–18:30 CET | Online 👉 Register: bit.ly/4hqdyky

🗓️ 2 days to go! Can #AI reshape how we detect and manage antimicrobial resistance? Find out in our #REVIVE webinar on 28 Oct, 17:00 CET. 👉 Register: revive.gardp.org/webinars/

🌍 At the GESDA Summit 2025, GARDP brought together scientists, funders, and policy leaders to explore bold solutions to #AMR. From AI-driven discovery research to access partnerships like cefiderocol, discussions made one thing clear: incremental change isn’t enough.

📊 The @who.int #GLASSReport 2025 shows rising resistance, especially among Gram-negative pathogens. At the launch, Dr. Jennifer Cohn said the data shows progress and urgency. Stronger surveillance, smarter antibiotic use and R&D are key to stay ahead of #AMR. 🎥 www.youtube.com/watch?v=GqRC...

📢 Exciting news! Selected articles from our Antimicrobial Viewpoints series will now be co-published in CMI Communications, @escmid.bsky.social's open-access journal. This collaboration will expand the reach and amplify the impact of these articles within the antimicrobial R&D community.

Thank you for attending #BioJapan 2025 It was a valuable opportunity to highlight the importance of international collaboration in the field of infectious diseases and the venue was filled with vibrant energy throughout✨

⏳ One month to go! Submit your abstract for ACC 2026 and join researchers worldwide shaping the future of #AMR. Topics can include child and maternal health, diagnostics, stewardship, innovation, AI and more. Deadline: 14 Nov 2025, 17:00 GMT 🔗 acc-conference.com#posters

📑 Drug-resistant infections have reached a tipping point. Without urgent action, #AMR deaths could rise by 70% by 2050. We need innovation and access to the right antibiotics. 🌍 🔗Read Dr Manica Balasegaram’s @theguardian.com piece: www.theguardian.com/global-devel...

🌍 At #WHS2025, GARDP’s Peter Beyer highlighted the impact of tech transfers in a #GSK session. "Technology transfer isn’t just about moving a production line; it’s about sharing know-how, building local capabilities, and ensuring that life-saving antibiotics can be sustainably manufactured."

🚨 @who.int reports a sharp global rise in antibiotic-resistant infections in hospitals. "Until now, the #AMR narrative has focused rightfully on the overuse of antibiotics, but this isn’t enough." - Manica Balasegaram @iansample.bsky.social for @theguardian.com www.theguardian.com/world/2025/o...

Nominations are now open for the second edition of the Penta Brighter Future Award (BFA), a biennial international award that celebrates inspiring contributions to maternal and child health worldwide. 👉 Submit your nomination: penta-id.org/bfa

We recently had the pleasure to discuss the progress of the #REVIVE programme and potential new activities in our second annual advisory meeting. A big Thank You to our 2026 REVIVE programme Advisory Group members.

When asked what GARDP expects from Japan in the fight against #AMR at the Nikkei-FT Infectious Disease Conference session, Rahul Dwivedi of #GARDP said: “Japan’s leadership is vital—especially in enabling access. With Shionogi and CHAI, we’re working to expand antibiotic access in 135 countries.”

GARDP joined 40+ global scientists in Geneva to help shape Drug Design for Global Health (dd4gh) — an AI and machine-learning platform being co-created by MMV and deepmirror. It aims to accelerate identification of promising drug compounds for global health research. 🔗 bit.ly/4h0I1pe

@who.int’s latest report on bacterial diagnostics highlights persistent gaps in rapid, affordable tools — especially where the need is greatest. GARDP’s Teri Roberts contributed as part of the WHO expert group. 🔗 Read more: www.who.int/publications...

@who.int’s new report shows the antibacterial R&D pipeline is shrinking — just 90 candidates remain in development, with limited innovation against critical pathogens. Strengthening both discovery and access is key to tackling AMR. 🔗Read the report: www.who.int/publications...

📝 Call for abstracts is open for #ACC2026! Researchers are invited to share their work on #AMR for short talks or poster presentations. 💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more. ⏳ Deadline: 14 Nov 2025, 17:00 GMT 🔗 acc-conference.com#posters

📍 Live from Osaka! At the Nikkei–FT Infectious Disease Conference 2025, GARDP's Rahul Dwivedi joined global health leaders to discuss the urgent need to strengthen R&D and funding for infectious diseases. 🗞️🔗Read the Nikkei article published last night covering it nikkei.com/article/DGXZ...

Finally, #BioJapan2025 starts tomorrow! 📍October 8–10 | Pacifico Yokohama This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨ 💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities! #SwissInnovation #AMR

🤝 Our team met with Shionogi’s CEO Dr Teshirogi, and Vice Chairperson Ms Sawada, to reaffirm our shared commitment to addressing #AMR. Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊

The @who.int’s updated Global Action Plan on #AMR, due in 2026, represents a pivotal opportunity to reshape the response to AMR. GARDP calls for focus on four key areas: 1️⃣ Access to antibiotics 2️⃣ Children & newborns 3️⃣ Public-private partnerships 4️⃣ Financing the AMR response 🔗 bit.ly/48NxgV8

"Ensuring access to antibiotics in LMICs doesn’t mean compromising stewardship. It means investing in systems – training, diagnostics, guidelines – that enable appropriate use from day one." – Jennifer Cohn, GARDP

This week, GARDP joined the PDP Funders Group in Thailand. Highlights from the visit 👇 🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women. 🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).

The GARDP team met with Member of the House of Representatives Hirofumi Niki to thank the Japanese Government for its support. 💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢

During our Tokyo visit, we met Ms Akiko Honda, Member of the House of Councillors, to discuss Japan’s role in global health🌍 💬 She underlined the importance of public support to strengthen cooperation, especially on #AMR. We shared how GARDP’s work delivers value to the Japanese public.

🎤 GARDP team members Alan Hennessy, Renata da Costa, and Dianna Taylor presented at #GAMRIC2025. Topics: 1️⃣ Discovery & Exploratory Research 2️⃣ Molecular characterization of CRE & CRPA in hospitalized patients from India Excited to share insights on antibiotic R&D and access!

That's a wrap on #GAMRIC2025! See today's highlights over on LinkedIn - t.ly/nr1sV Thanks to all who attended and we look forward to seeing you again next year for #GAMRIC2026. @carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

The rise in neonatal sepsis caused by drug-resistant bacteria is a major concern. GARDP is tackling this with our NeoSep clinical trial, currently underway in Africa and launching in Southeast Asia next year, aiming to identify effective antibiotic combinations. 🌍 www.newsweek.com/drug-resista...

🤝 The GARDP team visited Japan’s Ministry of Health, Labour and Welfare (International Affairs & Infectious Disease Divisions) to thank the Government of Japan for its support from 2020 to 2025. 💡 It was a chance to look back on our collab in tackling #AMR and discuss future partnership prospects.

🌍📊 At a roundtable with the GBD Independent Advisory Committee on data shaping global health strategy, Prof. Peter Piot and Prof. Christopher Murray shared insights, joined by Japanese MPs, researchers and foundations. GARDP’s Dr Peter Beyer and Dr Chieko Ikeda also contributed to the discussion.

The highlights of day 2 at #GAMRIC2025 are now live on our LinkedIn - t.ly/fgQ0i @carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

📢 On 18 Nov, Fleming Centre will light up London’s Piccadilly Lights to raise awareness of #AMR. 🩺 Share your story of how #antibiotics made a difference in your life — it could appear on the world’s biggest billboard. 🔗 www.fleminginitiative.org/thank-you-an...

In a GARDP-led session at the #GAMRIC, Alison Luckey, our Associate Director of Medical Sciences emphasized inclusivity in STI research.

🗣 Speaking at the #GAMRIC today, David Peterson reminded the AMR community that millions still lack the antibiotics they need. Fighting #AMR means fighting both resistance and inequity.

📍 Meet us in person at #GAMRIC2025 Come by, say hello, and learn how we’re driving antibiotic R&D and access for drug-resistant infections. From neonatal sepsis to STI innovations, we'd love to walk you through our portfolio.

🔦 Seamus in the spotlight at #GAMRIC. GARDP’s Seamus O’Brien joined experts today morning to discuss how to close the treatment gap for newborns with drug-resistant infections.

🔴 Live from London! GARDP is at the first-ever #GAMRIC. In his opening remarks for GAMRIC, Seamus O’Brien from GARDP reminded the audience why partnerships matter. More updates🔜

The inaugural Global AMR Innovators Conference (GAMRIC) has begun! Stay tuned for updates and join the conversation here or on Bluesky using #GAMRIC2025. @carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social

👩‍💻 How can #AI transform microbiology? Join Adrian Egli & Javier Fernández Domínguez at our next #REVIVE webinar to take a closer look at how AI is being used to analyse microbiological data and predict antimicrobial susceptibility. 📅 28 Oct | 17:00 CET 🔗 Register: bit.ly/42nlm0q

📍 GARDP at #WHS2025 in Berlin Our Deputy Executive Director, Peter Beyer will take part in two important sessions🔽:

🆕 In early October, the global #AMR research community will gather in London for the first-ever 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐌𝐑 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐨𝐫𝐬 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐆𝐀𝐌𝐑𝐈𝐂), and we’re proud to co-organize this inaugural event. Here’s where you can find GARDP:

CDC reports that the 'nightmare bacteria' with the NDM gene infections rose ~ 70% from 2019–2023 & is resistant to almost all antibiotics. At GARDP, Shionogi’s approved antibiotic cefiderocol & Bugworks’ BWC0977, now in clinical development, show activity against it. 🔗Read: bit.ly/4pFG05H

🌍 At #UNGA80, GARDP joined the Union for International Cancer Control (UICC) & Norwegian Cancer Society for a side event with leaders from Norway and Mozambique to mobilize efforts to fight #AMR and improve cancer care. 💬Jennifer Cohn underlined GARDP’s role in improving antibiotic access in LMICs.